Institutions · Entity Annotation Prototype (beta)

1articles mentioning institutions

1institution mentions

1distinct institutions extracted

0%of mentions human-reviewed

Active filtersEntity: NCT04033445 ×

NCT04033445

This institution is selected. Its supporting articles are shown below.

NCT040334451

Articles mentioning NCT04033445

1 articles · page 1 of 1

P210 Guselkumab efficacy in moderate to severe ulcerative colitis by extent of disease and inflammatory burden in the QUASAR maintenance study

gutjnl · abstract · 2026-06-23 · 1 matching annotations

81.6%

Johnson & Johnson NCT04033445 Guselkumab GUS ulcerative colitis

…h GUS 200mg SC q4w compared with GUS 100mg SC q8w.Study support Johnson & Johnson.References Sachen KL, et al. Guselkumab binding to CD64+ IL-23–…

Browse institutions

NCT04033445

Articles mentioning NCT04033445

P210 Guselkumab efficacy in moderate to severe ulcerative colitis by extent of disease and inflammatory burden in the QUASAR maintenance study